Keyword: Granules India

Merck's HPV shot Gardasil won approval in China, Lupin's Q4 sales in North America fell 13%, and China’s CANbridge gained a $25M series B.

India’s Granules bought a U.S. R&D facility in 2014 and is now ready to add manufacturing as part of plans to expand significantly in the U.S. market.

China updated national drug list with some blockbuster Western meds, Daiichi and ArQule’s tivantinib failed another trial, Dr. Reddy's got an FDA Form 483.

India’s Granules will do a significant expansion of its API bulk drug site in Vishakhapatnam, and is getting substantial help from the International Finance Corp. to pay for it.